These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 37650995)

  • 41. Molecular pathways in colorectal cancer.
    Al-Sohaily S; Biankin A; Leong R; Kohonen-Corish M; Warusavitarne J
    J Gastroenterol Hepatol; 2012 Sep; 27(9):1423-31. PubMed ID: 22694276
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Triptolide Loaded HER2-Targeted Nano-Drug Delivery System Significantly Suppressed the Proliferation of HER2-Positive and BRAF Mutant Colon Cancer.
    Yalikong A; Li XQ; Zhou PH; Qi ZP; Li B; Cai SL; Zhong YS
    Int J Nanomedicine; 2021; 16():2323-2335. PubMed ID: 33776436
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical relevance of colorectal cancer molecular subtypes.
    Rodriguez-Salas N; Dominguez G; Barderas R; Mendiola M; García-Albéniz X; Maurel J; Batlle JF
    Crit Rev Oncol Hematol; 2017 Jan; 109():9-19. PubMed ID: 28010901
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Research Advances of Lipid Nanoparticles in the Treatment of Colorectal Cancer.
    Zhang J; Ali K; Wang J
    Int J Nanomedicine; 2024; 19():6693-6715. PubMed ID: 38979534
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Establishment and characterization of cell lines from chromosomal instable colorectal cancer.
    Maletzki C; Gock M; Randow M; Klar E; Huehns M; Prall F; Linnebacher M
    World J Gastroenterol; 2015 Jan; 21(1):164-76. PubMed ID: 25574089
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancer.
    Overman MJ; Adam L; Raghav K; Wang J; Kee B; Fogelman D; Eng C; Vilar E; Shroff R; Dasari A; Wolff R; Morris J; Karunasena E; Pisanic TR; Azad N; Kopetz S
    Ann Oncol; 2018 Jan; 29(1):139-144. PubMed ID: 29069279
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CpG island methylator phenotype associates with low-degree chromosomal abnormalities in colorectal cancer.
    Cheng YW; Pincas H; Bacolod MD; Schemmann G; Giardina SF; Huang J; Barral S; Idrees K; Khan SA; Zeng Z; Rosenberg S; Notterman DA; Ott J; Paty P; Barany F
    Clin Cancer Res; 2008 Oct; 14(19):6005-13. PubMed ID: 18829479
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The CpG island methylator phenotype (CIMP) in colorectal cancer.
    Nazemalhosseini Mojarad E; Kuppen PJ; Aghdaei HA; Zali MR
    Gastroenterol Hepatol Bed Bench; 2013; 6(3):120-8. PubMed ID: 24834258
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gene mutation profiling in microsatellite instability colorectal cancer and its association with the efficacy of immunotherapy: A retrospective study.
    Liu Y; Cui K; Ma W
    Cancer Med; 2024 May; 13(9):e6910. PubMed ID: 38746969
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chromosomally and microsatellite stable colorectal carcinomas without the CpG island methylator phenotype in a molecular classification.
    Ostwald C; Linnebacher M; Weirich V; Prall F
    Int J Oncol; 2009 Aug; 35(2):321-7. PubMed ID: 19578746
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
    Kim JH; Bae JM; Cho NY; Kang GH
    Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113
    [TBL] [Abstract][Full Text] [Related]  

  • 52. KRAS mutated colorectal cancers with or without PIK3CA mutations: Clinical and molecular profiles inform current and future therapeutics.
    Voutsadakis IA
    Crit Rev Oncol Hematol; 2023 Jun; 186():103987. PubMed ID: 37059275
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A distinct DNA methylation profile associated with microsatellite and chromosomal stable sporadic colorectal cancers.
    Silver A; Sengupta N; Propper D; Wilson P; Hagemann T; Patel A; Parker A; Ghosh A; Feakins R; Dorudi S; Suraweera N
    Int J Cancer; 2012 Mar; 130(5):1082-92. PubMed ID: 21455990
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical features and mutation analysis of class 1/2/3 BRAF mutation colorectal cancer.
    Huang Y; Jia W; Zhao G; Zhao Y; Zhang S; Li Z; Wu G
    Chin Clin Oncol; 2024 Feb; 13(1):3. PubMed ID: 38372057
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk Factors and Incidence of Colorectal Cancer According to Major Molecular Subtypes.
    Wang L; He X; Ugai T; Haruki K; Lo CH; Hang D; Akimoto N; Fujiyoshi K; Wang M; Fuchs CS; Meyerhardt JA; Zhang X; Wu K; Chan AT; Giovannucci EL; Ogino S; Song M
    JNCI Cancer Spectr; 2021 Feb; 5(1):. PubMed ID: 33442661
    [TBL] [Abstract][Full Text] [Related]  

  • 56. BRAF mutation, CpG island methylator phenotype and microsatellite instability occur more frequently and concordantly in mucinous than non-mucinous colorectal cancer.
    Tanaka H; Deng G; Matsuzaki K; Kakar S; Kim GE; Miura S; Sleisenger MH; Kim YS
    Int J Cancer; 2006 Jun; 118(11):2765-71. PubMed ID: 16381005
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Long Noncoding RNA CCAT2 Induces Chromosomal Instability Through BOP1-AURKB Signaling.
    Chen B; Dragomir MP; Fabris L; Bayraktar R; Knutsen E; Liu X; Tang C; Li Y; Shimura T; Ivkovic TC; De Los Santos MC; Anfossi S; Shimizu M; Shah MY; Ling H; Shen P; Multani AS; Pardini B; Burks JK; Katayama H; Reineke LC; Huo L; Syed M; Song S; Ferracin M; Oki E; Fromm B; Ivan C; Bhuvaneshwar K; Gusev Y; Mimori K; Menter D; Sen S; Matsuyama T; Uetake H; Vasilescu C; Kopetz S; Parker-Thornburg J; Taguchi A; Hanash SM; Girnita L; Slaby O; Goel A; Varani G; Gagea M; Li C; Ajani JA; Calin GA
    Gastroenterology; 2020 Dec; 159(6):2146-2162.e33. PubMed ID: 32805281
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association Between Molecular Subtypes of Colorectal Tumors and Patient Survival, Based on Pooled Analysis of 7 International Studies.
    Phipps AI; Alwers E; Harrison T; Banbury B; Brenner H; Campbell PT; Chang-Claude J; Buchanan D; Chan AT; Farris AB; Figueiredo JC; Gallinger S; Giles GG; Jenkins M; Milne RL; Newcomb PA; Slattery ML; Song M; Ogino S; Zaidi SH; Hoffmeister M; Peters U
    Gastroenterology; 2020 Jun; 158(8):2158-2168.e4. PubMed ID: 32088204
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular Complexity of Colorectal Cancer: Pathways, Biomarkers, and Therapeutic Strategies.
    Yang Z; Wang X; Zhou H; Jiang M; Wang J; Sui B
    Cancer Manag Res; 2024; 16():1389-1403. PubMed ID: 39403607
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Chromosomal instability, microsatellite instability and CpG island methylator phenotype: roles in small intestinal carcinogenesis].
    Bläker H; Warth A; Kloor M; Schirmacher P
    Pathologe; 2011 Nov; 32 Suppl 2():181-4. PubMed ID: 21915661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.